0.4304
23-5月-25 13:45:00
15 分の遅延
株式
-0.0045
-1.03%
本日の幅
0.3901 - 0.4412
ISIN
N/A
ソース
NASDAQ
Tenaya Therapeutics Announces FDA Clearance of Investigational New Drug Application and Initiation of Phase 1 Safety Study for TN-301, an HDAC6 Inhibitor for Heart Failure with Preserved Ejection Fraction
06 9 2022 05:00:02 提供 Nasdaq GlobeNewswire
Tenaya Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
10 8 2022 13:01:00 提供 Nasdaq GlobeNewswire
Tenaya Therapeutics Publishes Preclinical Data in Science Translational Medicine Detailing Discovery of HDAC6 Inhibitor for Treatment of Heart Failure
06 7 2022 11:00:00 提供 Nasdaq GlobeNewswire